Recent News

• 06.07.2026 - Managing Passive Transfer Variability at Calf Ranches: Effects of Hyperimmunized Bovine Colostrum Supplementation on Health Outcomes
• 06.07.2026 - First Defense Technology® Field Demonstration Summary of a field demonstration to evaluate the impact of a First Defense Technology® hyperimmune E/C colostrum powder on calf health.
• 05.15.2026 - Key reasons IgY paste/gel products do not provide lasting immune support to calves.
• 05.14.2026 - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
• 05.07.2026 - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026

Recent Filings

• 05.14.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2026 - EX-99.1 EX-99.1
• 05.14.2026 - 8-K Current report
• 05.13.2026 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 05.08.2026 - 8-K Current report
• 04.24.2026 - DEF 14A Other definitive proxy statements
• 04.23.2026 - 3 Initial statement of beneficial ownership of securities
• 04.23.2026 - 3 Initial statement of beneficial ownership of securities
• 04.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.16.2026 - 4 Statement of changes in beneficial ownership of securities